{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T07:21:19Z","timestamp":1649056879563},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.2515\/therapie\/2009024","type":"journal-article","created":{"date-parts":[[2009,8,10]],"date-time":"2009-08-10T11:31:33Z","timestamp":1249903893000},"page":"81-86","source":"Crossref","is-referenced-by-count":0,"title":["Apport des mod\u00e8les transg\u00e9niques dans la recherche de nouvelles cibles pharmacologiques dans l\u2019insuffisance cardiaque : l\u2019exemple du r\u00e9cepteur de l\u2019aldost\u00e9rone"],"prefix":"10.1016","volume":"64","author":[{"given":"C\u00e9line","family":"Latouche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Jaisser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.2515\/therapie\/2009024_bb0005","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","article-title":"Remodeling of the rat right and left ventricles in experimental hypertension","volume":"67","author":"Brilla","year":"1990","journal-title":"Circ Res"},{"issue":"5","key":"10.2515\/therapie\/2009024_bb0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism","volume":"25","author":"Brilla","year":"1993","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"10.2515\/therapie\/2009024_bb0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.HYP.24.1.30","article-title":"Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension","volume":"24","author":"Robert","year":"1994","journal-title":"Hypertension"},{"issue":"6","key":"10.2515\/therapie\/2009024_bb0020","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1172\/JCI117269","article-title":"Mineralocorticoids, hypertension, and cardiac fibrosis","volume":"93","author":"Young","year":"1994","journal-title":"J Clin Invest"},{"issue":"3","key":"10.2515\/therapie\/2009024_bb0025","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.RES.71.3.503","article-title":"Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor","volume":"71","author":"Lombes","year":"1992","journal-title":"Circ Res"},{"issue":"2","key":"10.2515\/therapie\/2009024_bb0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.CIR.92.2.175","article-title":"Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart","volume":"92","author":"Lombes","year":"1995","journal-title":"Circulation"},{"issue":"8","key":"10.2515\/therapie\/2009024_bb0035","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0002-9149(96)00465-1","article-title":"Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES])","volume":"78","year":"1996","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.2515\/therapie\/2009024_bb0040","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"issue":"3","key":"10.2515\/therapie\/2009024_bb0045","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cardfail.2006.01.003","article-title":"Appropriateness of spironolactone prescribing in heart failure patients: a population-based study","volume":"12","author":"Ko","year":"2006","journal-title":"J Card Fail"},{"issue":"14","key":"10.2515\/therapie\/2009024_bb0050","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.2515\/therapie\/2009024_bb0055","first-page":"S49","article-title":"Regulation of sodium transport by steroid hormones","volume":"65","author":"Bonvalet","year":"1998","journal-title":"Kidney International"},{"key":"10.2515\/therapie\/2009024_bb0060","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1146\/annurev.physiol.64.082101.143243","article-title":"Epithelial sodium channel and the control of sodium balance: interaction between genetic and environmental factors","volume":"64","author":"Rossier","year":"2002","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"10.2515\/therapie\/2009024_bb0065","doi-asserted-by":"crossref","first-page":"F181","DOI":"10.1152\/ajprenal.2001.280.2.F181","article-title":"Multiple aspects of mineralocorticoid selectivity","volume":"280","author":"Farman","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.2515\/therapie\/2009024_bb0070","doi-asserted-by":"crossref","DOI":"10.1621\/nrs.05012","article-title":"The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology","volume":"5","author":"Viengchareun","year":"2007","journal-title":"Nucl Recept Signal"},{"issue":"4812","key":"10.2515\/therapie\/2009024_bb0075","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"issue":"2-5","key":"10.2515\/therapie\/2009024_bb0080","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jsbmb.2004.12.010","article-title":"RALES, EPHESUS and redox","volume":"93","author":"Funder","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Pt 1","key":"10.2515\/therapie\/2009024_bb0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1469-7793.2001.0151k.x","article-title":"Effects of aldosterone on transient outward K+ current density in rat ventricular myocytes","volume":"537","author":"Benitah","year":"2001","journal-title":"J Physiol"},{"issue":"12","key":"10.2515\/therapie\/2009024_bb0090","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/01.RES.85.12.1139","article-title":"Aldosterone upregulates Ca(2+) current in adult rat cardiomyocytes","volume":"85","author":"Benitah","year":"1999","journal-title":"Circ Res"},{"issue":"4","key":"10.2515\/therapie\/2009024_bb0095","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/HYPERTENSIONAHA.108.114223","article-title":"Corticosteroids and redox potential modulate spontaneous contractions in isolated rat ventricular cardiomyocytes","volume":"52","author":"Rossier","year":"2008","journal-title":"Hypertension"},{"issue":"2","key":"10.2515\/therapie\/2009024_bb0100","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cardiores.2005.05.009","article-title":"Aldosterone increases Ttype calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes","volume":"67","author":"Lalevee","year":"2005","journal-title":"Cardiovasc Res"},{"issue":"Pt 1","key":"10.2515\/therapie\/2009024_bb0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1113\/jphysiol.2005.092692","article-title":"A direct relationship between plasma aldosterone and cardiac L-type Ca2+ current in mice","volume":"569","author":"Perrier","year":"2005","journal-title":"J Physiol"},{"issue":"4","key":"10.2515\/therapie\/2009024_bb0110","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/en.2006-1438","article-title":"Early aldosterone-regulated genes in cardiomyocytes: clues to cardiac remodeling?","volume":"148","author":"Fejes-Toth","year":"2007","journal-title":"Endocrinology"},{"key":"10.2515\/therapie\/2009024_bb0115","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/978-3-540-35109-2_16","article-title":"Animal models in cardiovascular diseases: new insights from conditional models","volume":"178","author":"Nguyen","year":"2007","journal-title":"Handb Exp Pharmacol"},{"issue":"42","key":"10.2515\/therapie\/2009024_bb0120","doi-asserted-by":"crossref","first-page":"38911","DOI":"10.1074\/jbc.M103984200","article-title":"Alteration of cardiac and renal functions in transgenic mice overexpressing human mineralocorticoid receptor","volume":"276","author":"Le Menuet","year":"2001","journal-title":"J Biol Chem"},{"issue":"23","key":"10.2515\/therapie\/2009024_bb0125","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1161\/CIRCULATIONAHA.104.503706","article-title":"Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias","volume":"111","author":"Ouvrard-Pascaud","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.2515\/therapie\/2009024_bb0130","doi-asserted-by":"crossref","first-page":"R946","DOI":"10.1152\/ajpregu.00402.2006","article-title":"Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker","volume":"292","author":"Ohtani","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"5","key":"10.2515\/therapie\/2009024_bb0135","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1291\/hypres.30.427","article-title":"Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts","volume":"30","author":"Takeda","year":"2007","journal-title":"Hypertens Res"},{"issue":"1","key":"10.2515\/therapie\/2009024_bb0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/10739680490266207","article-title":"Enhancement of glucocorticoid and mineralocorticoid receptor density in the microcirculation of the spontaneously hypertensive rat","volume":"11","author":"DeLano","year":"2004","journal-title":"Microcirculation"},{"issue":"4","key":"10.2515\/therapie\/2009024_bb0145","first-page":"745","article-title":"Enhanced expression of mineralocorticoid receptors in the heart after the myocardial infarct in rats","volume":"58","author":"Milik","year":"2007","journal-title":"J Physiol Pharmacol"},{"issue":"6","key":"10.2515\/therapie\/2009024_bb0150","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1161\/HYPERTENSIONAHA.108.117531","article-title":"Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling","volume":"52","author":"Di Zhang","year":"2008","journal-title":"Hypertension"},{"issue":"9","key":"10.2515\/therapie\/2009024_bb0155","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1096\/fj.05-4642fje","article-title":"Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase","volume":"20","author":"Johar","year":"2006","journal-title":"Faseb J"},{"issue":"6","key":"10.2515\/therapie\/2009024_bb0160","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1161\/HYPERTENSIONAHA.108.117531","article-title":"Cross-talk between ineralocorticoid and angiotensin II signaling for cardiac remodeling","volume":"52","author":"Di Zhang","year":"2008","journal-title":"Hypertension"},{"issue":"5","key":"10.2515\/therapie\/2009024_bb0165","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cardfail.2004.02.010","article-title":"Eplerenone, a selective aldosterone blocker, improves diastolic function in aged rats with small-to-moderate myocardial infarction","volume":"10","author":"Masson","year":"2004","journal-title":"J Card Fail"},{"issue":"19","key":"10.2515\/therapie\/2009024_bb0170","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1161\/CIRCULATIONAHA.105.571653","article-title":"Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study","volume":"112","author":"Izawa","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.2515\/therapie\/2009024_bb0175","first-page":"103","article-title":"Aldosterone receptor antagonists induce favorable cardiac remodeling in diastolic heart failure patients","volume":"59","author":"Orea-Tejeda","year":"2007","journal-title":"Rev Invest Clin"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716306047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716306047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T07:31:58Z","timestamp":1554276718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716306047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0040595716306047"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2009024","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}